Claudins, Inflammation and Epithelial-Mesenchymal Transition in Gastric Tissue | OMICS International | Abstract
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Claudins, Inflammation and Epithelial-Mesenchymal Transition in Gastric Tissue

Rendon-Huerta E*, Chavarria-Velazquez CO and Montaño LF

Department of Cell and Tissue Biology, Immunobiology Laboratory, UNAM, Mexico

*Corresponding Author:
Rendon-Huerta E
Faculty of Medicine, Department of Cell and Tissue Biology
Immunobiology Laboratory, UNAM, Mexico
E-mail: [email protected]

Received date: September 26, 2013; Accepted date: October 26, 2013; Published date: November 02, 2013

Citation: Rendon-Huerta E, Chavarria-Velazquez CO, Montaño LF (2013) Claudins, Inflammation and Epithelial-Mesenchymal Transition in Gastric Tissue. J Gastroint Dig Syst 3:149. doi:10.4172/2161-069X.1000149

Copyright: © 2013 Rendon-Huerta E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Gastric cancer is a serious worldwide health burden. It is the fourth most frequently diagnosed cancer with an estimated 1 million new cases per year. The disease is often diagnosed in advanced stages and is associated with a poor prognosis for patients. It exhibits heterogeneity in clinical, biologic, and genetic aspects. Although H. pylori is the best studied risk factor, interleukins associated with chronic inflammation, disruption of tight junctions especially claudins, MERK/ERK signaling pathways and cancer stem cells have key roles in carcinogenesis and progression. An in-depth understanding of the role that inflammation and modified tight junction proteins play in epithelial-mesenchymal transition may improve our understanding of the cancer process and lead to the recognition of new biomarkers for early diagnosis, and possibly, improved therapeutics.